Early Serum Clusterin Reduction is Associated with Weight Loss and Type 2 Diabetes Remission after Bariatric Surgery - Takeaways - MDSpire

Early Serum Clusterin Reduction is Associated with Weight Loss and Type 2 Diabetes Remission after Bariatric Surgery

  • By

  • Yiming Si

  • Yinfang Tu

  • Yufei Wang

  • Hongwei Zhang

  • Xiaodong Han

  • Weijie Liu

  • Pin Zhang

  • Xiaojing Ma

  • Haoyong Yu

  • Yuqian Bao

  • May 18, 2026

  • 0 min

Share

  • 1

    Bariatric surgery effectively induces weight loss and promotes remission of type 2 diabetes in patients with obesity.

  • 2

    Clusterin levels are associated with insulin resistance, obesity, and type 2 diabetes, decreasing with weight loss.

  • 3

    This study investigates changes in clusterin levels post-surgery and their correlation with weight loss and diabetes remission.

  • 4

    A cohort of 75 patients underwent metabolic assessments before and after bariatric surgery to analyze clusterin levels.

  • 5

    The study aims to clarify the relationship between clusterin changes and metabolic outcomes following bariatric procedures.

Original Source(s)

Early Serum Clusterin Reduction is Associated with Weight Loss and Type 2 Diabetes Remission after Bariatric Surgery

  • by Yiming Si, Yinfang Tu, Yufei Wang, Hongwei Zhang, Xiaodong Han, Weijie Liu, Pin Zhang, Xiaojing Ma, Haoyong Yu, Yuqian Bao

  • May 18, 2026

Related Content

Side Effects: They Googled It

Patients are mining Reddit and TikTok for symptom intel while you're not — and a small study calls it epistemic injustice. Different knowledge, mutually unrecognized. Maybe ask where they've been reading before you wave it off as anecdote.

NIH researchers identify avenue for enhanced GLP-1-induced weight loss

  • May 22, 2026

Opposing gastric and jejunal regulation of CELA2A in obesity and after Roux-en-Y gastric bypass suggests a role in gastrointestinal metabolic signaling